阅读说明：本技术 肺癌专用型临床营养配方食品及其制备方法 (Special clinical nutritional formula food for lung cancer and preparation method thereof ) 是由 尤俊 于 2020-05-31 设计创作，主要内容包括：本发明适用于营养食品技术领域,提供了肺癌专用型临床营养配方食品及其制备方法,配方包括蛋白质、多不饱和脂肪、维生素A、维生素C、维生素E、维生素D、还原型谷关甘肽、膳食纤维、钙、铁、铜、镁、锌、硒、壳寡糖、谷氨酰胺、大豆异黄酮、姜黄素、茯苓酸,然后将配方原料消毒分装到瓶中,制成可食用的营养食品,针对肺癌患者饮食结构不合理、营养不均匀等不良现状,主要是通过膳食调控,补充多种维生素、矿物质、搭配药食同源和新资源食品,来改善肺癌患者营养结构,辅助改善机体健康状况。(The invention is suitable for the technical field of nutritional foods, and provides a clinical nutritional formula food special for lung cancer and a preparation method thereof.)

1. The special clinical nutritional formula food for the lung cancer is characterized in that: comprising the following components in weight: 1500g to 2000g of protein, 100g to 200g of polyunsaturated fat, 100g to 500g of vitamin A, 300g to 400g of vitamin C, 300g to g g to 400g of vitamin E, 300g to g g to 400g of vitamin D, 50g to 70g of reduced glutathione, 800g to 1000g of dietary fiber, 200g to 300g of calcium, 100g to 200g of ferrum, 100g to 200g of copper, 100g to 200g of magnesium, 100g to 200g of zinc, 100g to 200g of selenium, 800g to 1000g of chitosan oligosaccharide, 1000g to 1500g of glutamine, 50g to 100g of soybean isoflavone, 50g to 100g of curcumin and 50g to 100g of pachymic acid.

2. The lung cancer-specific clinical nutritional formula according to claim 1, wherein: comprising the following components in weight:

1800g of protein, 100g of polyunsaturated fat, 200g g of vitamin A, 300g g of vitamin C, 300g g of vitamin E, 300g g of vitamin D, 50g of reduced glutathione, 800g of dietary fiber, 200g of calcium, 100g of iron, 100g of copper, 100g of magnesium, 100g of zinc, 100g of selenium, 800g of chitosan oligosaccharide, 50g to 100g of soybean isoflavone, 50g to 100g of curcumin and 50g to 100g of pachymic acid.

3. The lung cancer-specific clinical nutritional formula according to claim 1, wherein:

the protein raw material is selected from one or more of soybean protein isolate, soybean peptide, wheat oligopeptide and corn oligopeptide powder;

the polyunsaturated fat is selected from one or more of oleum Olivarum microcapsule powder, Perilla oil microcapsule powder, docosahexaenoic acid oil, arachidonic acid oil, fish oil microcapsule powder, oleum Lini microcapsule powder, and oleum Camelliae microcapsule powder.

4. The lung cancer-specific clinical nutritional formula according to claim 1, wherein:

the raw material of vitamin A is selected from one or more of retinyl acetate, retinyl palmitate, all-trans retinol and beta-carotene;

the raw material of the vitamin C is selected from one or more of L-ascorbic acid, L-calcium ascorbate, L-sodium ascorbate, L-potassium ascorbate, magnesium ascorbyl phosphate and L-ascorbic acid-6-palmitate;

the raw material of vitamin E is selected from one or more of d-alpha-tocopherol, dl-alpha-tocopherol, d-alpha-tocopherol acetate, dl-alpha-tocopherol acetate, mixed tocopherol concentrate, vitamin E calcium succinate, d-alpha-tocopherol succinate and dl-alpha-tocopherol succinate;

the raw material of the vitamin D is selected from one or more of ergocalciferol and cholecalciferol.

5. The lung cancer-specific clinical nutritional formula according to claim 1, wherein:

the calcium is selected from one or more of calcium carbonate, calcium gluconate, calcium citrate, calcium lactate, L-calcium lactate, calcium hydrogen phosphate, calcium L-threonate, calcium glycinate, calcium aspartate, calcium citrate malate, calcium acetate, calcium chloride, tricalcium phosphate, vitamin E calcium succinate, calcium glycerophosphate, calcium oxide, and calcium sulfate;

the raw material of the iron is selected from one or more of ferrous sulfate, ferrous gluconate, ferric ammonium citrate, ferrous fumarate, ferric citrate, ferrous lactate, hemin, ferric pyrophosphate, iron porphyrin, ferrous glycinate, reduced iron, sodium ferric ethylenediamine tetraacetate, carbonyl iron powder, ferrous carbonate, ferrous citrate, ferrous fumarate, ferrous succinate, heme iron and electrolytic iron;

the zinc raw material is selected from one or more of zinc sulfate, zinc gluconate, zinc oxide, zinc lactate, zinc citrate, zinc glycinate, zinc chloride, zinc acetate and zinc carbonate;

the selenium raw material is selected from one or more of sodium selenite, sodium selenate, selenoprotein, selenium-rich edible fungus powder, L-selenium-methyl selenocysteine, seleno-carrageenan and selenium-rich yeast.

6. The lung cancer-specific clinical nutritional formula according to claim 1, wherein:

the vitamin C preparation is one or more of L-ascorbic acid, L-calcium ascorbate, L-sodium ascorbate, L-potassium ascorbate, magnesium ascorbyl phosphate, and L-ascorbic acid-6-palmitate;

the vitamin A preparation is one or more of retinyl acetate, retinyl palmitate, all-trans retinol, and beta-carotene;

vitamin E is one or more of d-alpha-tocopherol, dl-alpha-tocopherol, d-alpha-tocopherol acetate, dl-alpha-tocopherol acetate, mixed tocopherol concentrate, vitamin E calcium succinate, d-alpha-tocopherol succinate, and dl-alpha-tocopherol succinate.

7. The method for preparing the lung cancer-specific clinical nutritional formula food according to claims 1 to 6, wherein the food comprises: the method comprises the following steps:

s1, weighing protein, polyunsaturated fat, vitamin A, vitamin C, vitamin E, vitamin D, reduced glutathione, dietary fiber, calcium, iron, copper, magnesium, zinc, selenium, chitosan oligosaccharide, glutamine, soybean isoflavone, curcumin and pachymic acid according to weight, sterilizing, and mixing uniformly to obtain a food raw material;

s2, packaging the food raw materials into bags with the weight of 30g per bag to form the food bags.

Technical Field

The invention belongs to the technical field of nutritional foods, and particularly relates to a special clinical nutritional formula food for lung cancer and a preparation method thereof.

Background

Lung cancer is one of the most common malignant tumors worldwide, and both the morbidity and mortality of lung cancer are the first of cancers. The latest world health organization reports indicate that the incidence rates of lung cancer in men and women are all in the front of the world, and the incidence rate of women is obviously higher than that in developed countries such as Europe, America and the like. The new cases in the year are the first of the tumors in men, and the women are only second to breast cancer. The annual fatality rate is the first of malignant tumors. Chemotherapy is an important auxiliary treatment means after lung cancer patients operate, and has irreplaceable effects in the aspects of controlling the development of local focuses, eliminating residual and micrometastasis focuses of lung cancer, controlling distant metastasis of lung cancer in middle and late stages and the like. Patients with lung cancer all have malnutrition of different degrees, and chemotherapy drugs can cause gastrointestinal reactions, which leads to aggravation of malnutrition, and leads to reduction of quality of life and life time of patients. Proper nutrition therapy can improve the nutritional status of patients, improve the immune function of organisms, enhance the anticancer capability, improve the tolerance of patients to chemotherapy and alleviate the adverse reactions of medicines, thereby improving the prognosis.

The change of appetite, the change of substance and energy metabolism of malignant tumor patients after illness are the main mechanisms causing malnutrition. The change of appetite, the change of substance and energy metabolism of malignant tumor patients after illness are the main mechanisms causing malnutrition. Most of lung cancer chemotherapy patients have no obvious hypoproteinemia, but the patients have 'energy liability' due to changes of substance and energy metabolism caused by inappetence for a long time, excessive psychological stress, surgical stress and the like. The 'energy liability' can cause the increase of the risk of complications and the prolongation of hospitalization time, the long-term inhibition of the immune function by tumor load of muscle or fat is caused by the reduction of organ functions, so that the postoperative immune function of a patient is lower, the recurrence and metastasis of tumors are accelerated, the effectiveness of tumor treatment is influenced, the adverse reaction of chemoradiotherapy is increased, the life quality of the patient is reduced, the survival time of the tumor patient is shortened, and the potential risk is brought to the subsequent treatment of the patient. Therefore, the nutrition support treatment is very important after the lung cancer patient is treated by chemotherapy. In 2009, the american society for parenteral and enteral nutrition issued guidelines for the treatment of nutritional support for clinical tumor patients, again emphasizing that there was no evidence that nutritional support would promote tumor growth. This also provides a theoretical basis for the administration of nutritional support therapy following lung cancer chemotherapy.

Studies have shown that the incidence of protein-energy malnutrition is high in stage iii-iv lung cancer patients who have nutritional and immune dysfunction from the outset, particularly cellular immune dysfunction, and therefore most patients require some form of nutritional therapy.

Disclosure of Invention

The invention provides a special clinical nutritional formula food for lung cancer and a preparation method thereof, and aims to solve the problems of unreasonable dietary structure, uneven nutrition and the like of lung cancer patients, mainly improve the nutritional structure of the lung cancer patients and assist in improving the health condition of organisms by supplementing various vitamins and minerals, matching medicinal and edible foods and new resource foods through dietary regulation.

The invention is realized in such a way that the special clinical nutrition formula food for the lung cancer comprises the following components in parts by weight: 1500g to 2000g of protein, 100g to 200g of polyunsaturated fat, 100g to 500g of vitamin A, 300g to 400g of vitamin C, 300g to g g to 400g of vitamin E, 300g to g g to 400g of vitamin D, 50g to 70g of reduced glutathione, 800g to 1000g of dietary fiber, 200g to 300g of calcium, 100g to 200g of ferrum, 100g to 200g of copper, 100g to 200g of magnesium, 100g to 200g of zinc, 100g to 200g of selenium, 800g to 1000g of chitosan oligosaccharide, 1000g to 1500g of glutamine, 50g to 100g of soybean isoflavone, 50g to 100g of curcumin and 50g to 100g of pachymic acid.

Preferably, the following components are included by weight: 1800g of protein, 100g of polyunsaturated fat, 200g g of vitamin A, 300g g of vitamin C, 300g g of vitamin E, 300g g of vitamin D, 50g of reduced glutathione, 800g of dietary fiber, 200g of calcium, 100g of iron, 100g of copper, 100g of magnesium, 100g of zinc, 100g of selenium, 800g of chitosan oligosaccharide, 50g to 100g of soybean isoflavone, 50g to 100g of curcumin and 50g to 100g of pachymic acid.

Preferably, the protein raw material is selected from one or more of soybean protein isolate, soybean peptide, wheat oligopeptide and corn oligopeptide powder;

the polyunsaturated fat is selected from one or more of oleum Olivarum microcapsule powder, Perilla oil microcapsule powder, docosahexaenoic acid oil, arachidonic acid oil, fish oil microcapsule powder, oleum Lini microcapsule powder, and oleum Camelliae microcapsule powder.

Preferably, the raw material of the vitamin A is selected from one or more of retinyl acetate, retinyl palmitate, all-trans retinol and beta-carotene;

the raw material of the vitamin C is selected from one or more of L-ascorbic acid, L-calcium ascorbate, L-sodium ascorbate, L-potassium ascorbate, magnesium ascorbyl phosphate and L-ascorbic acid-6-palmitate;

the raw material of vitamin E is selected from one or more of d-alpha-tocopherol, dl-alpha-tocopherol, d-alpha-tocopherol acetate, dl-alpha-tocopherol acetate, mixed tocopherol concentrate, vitamin E calcium succinate, d-alpha-tocopherol succinate and dl-alpha-tocopherol succinate;

the raw material of the vitamin D is selected from one or more of ergocalciferol and cholecalciferol.

Preferably, the calcium raw material is selected from one or more of calcium carbonate, calcium gluconate, calcium citrate, calcium lactate L-phosphate, calcium hydrogen phosphate, calcium L-threonate, calcium glycinate, calcium aspartate, calcium citrate malate, calcium acetate, calcium chloride, tricalcium phosphate, calcium vitamin E succinate, calcium glycerophosphate, calcium oxide and calcium sulfate;

the raw material of the iron is selected from one or more of ferrous sulfate, ferrous gluconate, ferric ammonium citrate, ferrous fumarate, ferric citrate, ferrous lactate, hemin, ferric pyrophosphate, iron porphyrin, ferrous glycinate, reduced iron, sodium ferric ethylenediamine tetraacetate, carbonyl iron powder, ferrous carbonate, ferrous citrate, ferrous fumarate, ferrous succinate, heme iron and electrolytic iron;

the zinc raw material is selected from one or more of zinc sulfate, zinc gluconate, zinc oxide, zinc lactate, zinc citrate, zinc glycinate, zinc chloride, zinc acetate and zinc carbonate;

the selenium raw material is selected from one or more of sodium selenite, sodium selenate, selenoprotein, selenium-rich edible fungus powder, L-selenium-methyl selenocysteine, seleno-carrageenan and selenium-rich yeast.

Preferably, the vitamin C preparation is one or more of L-ascorbic acid, L-calcium ascorbate, L-sodium ascorbate, L-potassium ascorbate, magnesium ascorbyl phosphate and L-ascorbic acid-6-palmitate;

the vitamin A preparation is one or more of retinyl acetate, retinyl palmitate, all-trans retinol, and beta-carotene;

vitamin E is one or more of d-alpha-tocopherol, dl-alpha-tocopherol, d-alpha-tocopherol acetate, dl-alpha-tocopherol acetate, mixed tocopherol concentrate, vitamin E calcium succinate, d-alpha-tocopherol succinate, and dl-alpha-tocopherol succinate.

The invention also provides a preparation method of the special clinical nutrition formula food for the lung cancer, which is suitable for any one of the special clinical nutrition formula foods for the lung cancer and comprises the following steps:

s1, weighing the vitamin C preparation, the vitamin A preparation and the vitamin E preparation according to the weight, and premixing to obtain the compound vitamin; weighing protein, polyunsaturated fat, vitamin A, vitamin C, vitamin E, vitamin D, reduced glutathione, dietary fiber, calcium, ferrum, copper, magnesium, zinc, selenium, chitosan oligosaccharide, glutamine, soybean isoflavone, curcumin and pachymic acid according to weight, sterilizing, and mixing uniformly to obtain food raw materials;

s2, packaging the food raw materials into bags with the weight of 30g per bag to form the food bags.

Compared with the prior art, the invention has the beneficial effects that: according to the special clinical nutrition formula food for lung cancer and the preparation method thereof, aiming at the poor current situations of unreasonable dietary structure, uneven nutrition and the like of a lung cancer patient, protein, polyunsaturated fat, vitamin A, vitamin C, vitamin E, vitamin D, reduced glutathione, dietary fiber, calcium, iron, copper, magnesium, zinc, selenium, chitosan oligosaccharide, glutamine, soybean isoflavone, curcumin and pachymic acid are prepared in the formula, and the special clinical nutrition formula food for lung cancer and the preparation method thereof mainly supplement various vitamins and minerals through diet regulation and control, match with food with homology of medicine and food and new resources, improve the nutritional structure of the lung cancer patient and assist in improving the health condition of the organism.

Drawings

FIG. 1 is a schematic flow chart of a preparation method of the lung cancer-dedicated clinical nutritional formula food of the present invention.

Detailed Description

In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention is described in further detail below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.

The invention provides a technical scheme that: the lung cancer special clinical nutrition formula food comprises the following components in parts by weight: 1800g of protein, 100g of polyunsaturated fat, 200g g of vitamin A, 300g g of vitamin C, 300g g of vitamin E, 300g g of vitamin D, 50g of reduced glutathione, 800g of dietary fiber, 200g of calcium, 100g of iron, 100g of copper, 100g of magnesium, 100g of zinc, 100g of selenium, 800g of chitosan oligosaccharide, 50g to 100g of soybean isoflavone, 50g to 100g of curcumin and 50g to 100g of pachymic acid.

In the present embodiment, the high-quality plant protein source may be one or more of soy protein isolate, soy peptide, wheat oligopeptide and corn oligopeptide powder. The protein can promote the cellular immunity and the humoral immunity of the organism, is an important material basis of the immune network of the organism and has an important function for maintaining the immune monitoring of the organism. The protein intake of the body is low, and the regulation and control effect of the protein on the immune function of the body can be weakened, so that the tumor cells escape from immune monitoring.

The polyunsaturated fat is derived from one or more of oleum Olivarum microcapsule powder, Perilla oil microcapsule powder, docosahexaenoic acid oil, arachidonic acid oil, fish oil microcapsule powder, oleum Lini microcapsule powder, and oleum Camelliae microcapsule powder.

In this embodiment, vitamin a may be derived from one or a combination of more of retinyl acetate, retinyl palmitate, all-trans retinol, and beta-carotene. The intake of vitamin a and beta-carotene is beneficial to reduce the risk of lung cancer. Carotenoids and vitamin a have several similar biological activities, such as antioxidant, malignant tumor growth inhibitory and apoptosis inducing effects, carotenoids can influence cell growth, regulate gene expression and immune response, and prevention of cancer through dietary intake of carotenoids involves various mechanisms, including effects on intercellular junction communication, growth factor signaling, cell cycle, differentiation-related proteins, retinoic acid receptors, antioxidant response elements, nuclear receptors, AP-1 transcription complex, Wnt/β -catenin signaling pathway and inflammatory factors. In addition, carotenoids stimulate B cell proliferation, activate the activity of T lymphocytes, macrophages and cytotoxic T cells, stimulate effector T cell function and produce cytokines.

The vitamin C is selected from one or more of L-ascorbic acid, L-calcium ascorbate, L-sodium ascorbate, L-potassium ascorbate, magnesium ascorbyl phosphate, and L-ascorbic acid-6-palmitate. Vitamin C is acidic, also called ascorbic acid, has wide antioxidant activity and has the effect of promoting oxidation under specific conditions, and the dual effects enable the vitamin C to be one place in the prevention and treatment of tumors. On one hand, the antioxidant effect of the vitamin C can prevent certain tumors from happening and reduce the side effect of the antitumor drugs; on the other hand, the oxidation promoting effect of the composition has a tumor killing effect. In addition, dietary and serum vitamin C levels are closely related to lung function and forced vital capacity, vitamin C has a protective effect on decreased lung function. Even for smokers and abstinents, vitamin C can delay the decline of lung function. There is increasing evidence that vitamin C is beneficial in protecting lung function. Vitamin C has effects of promoting metabolism, removing toxic substances, enhancing immunity, and scavenging free radicals.

Vitamin E can directly scavenge free radicals and protect cell membrane. Vitamin E can also transfer electrons to free radicals, thereby reducing the lipid peroxidation in the mucous membrane caused by the free radicals and protecting the mucous membrane. Meanwhile, the vitamin E can also maintain the integrity of a nerve biomembrane and prevent peripheral neurons in intestinal mucosa from being attacked by excitotoxic injury and free radicals. Vitamin E is one or more of d-alpha-tocopherol, dl-alpha-tocopherol, d-alpha-tocopherol acetate, dl-alpha-tocopherol acetate, mixed tocopherol concentrate, vitamin E calcium succinate, d-alpha-tocopherol succinate, and dl-alpha-tocopherol succinate.

Vitamin D plays an important role in the process of cancer occurrence and progression through mechanisms of antiproliferation, apoptosis promotion, differentiation promotion, anti-angiogenesis and the like. The vitamin D is derived from one or more of ergocalciferol and cholecalciferol.

The dietary fiber is one or more of inulin, polydextrose, galacto-oligosaccharide, fructo-oligosaccharide, xylo-oligosaccharide, isomalto-oligosaccharide, resistant dextrin, soybean fiber, etc. Dietary fiber can prevent canceration induced by some chemical carcinogens, and can reduce canceration by regulating hormone or endogenous tumor inhibitor in vivo. Intake of cellulose can also significantly reduce the incidence of lung cancer, and the inhibition mechanism may be that it affects the production of certain carcinogens or pro-carcinogens; has regulating effect on endocrine system, thereby influencing the generation and development of tumor.

Calcium is a mediator of reactive oxygen species, and elevated levels of cytoplasmic Ca2+ may lead to influx of reactive oxygen species into mitochondria and nuclei, potentially affecting DNA stability and increasing the risk of cancer. The calcium is selected from one or more of calcium carbonate, calcium gluconate, calcium citrate, calcium lactate, L-calcium lactate, calcium hydrogen phosphate, calcium L-threonate, calcium glycinate, calcium aspartate, calcium citrate malate, calcium acetate, calcium chloride, tricalcium phosphate, vitamin E calcium succinate, calcium glycerophosphate, calcium oxide, and calcium sulfate.

Iron is an essential element for maintaining cell function and has a strong ability to catalyze the reaction of free radicals with peroxidation. The iron is selected from one or more of ferrous sulfate, ferrous gluconate, ferric ammonium citrate, ferrous fumarate, ferric citrate, ferrous lactate, hemin, ferric pyrophosphate, ferriporphyrin, ferrous glycinate, reduced iron, sodium ferric ethylenediamine tetraacetate, carbonyl iron powder, ferrous carbonate, ferrous citrate, ferrous fumarate, ferrous succinate, heme iron, and electrolytic iron.

Selenium is an essential component of glutathione oxidase, and the possible mechanism of selenium cancer prevention and resistance is that selenium can regulate the activities of glutathione peroxidase and glutathione phospholipid hydroperoxide, prevent peroxidation, protect biological membranes from being damaged and prevent mutation. Selenium can play an anti-tumor role through mechanisms such as free radical removal, oxidation resistance, immunoregulation and the like. The selenium is selected from one or more of sodium selenite, sodium selenate, selenoprotein, selenium-rich edible fungus powder, L-selenium-methyl selenocysteine, seleno carrageenan, and selenium-rich yeast.

The selenium is added in the form of one or more of sodium selenite, selenium-enriched yeast, and L-selenium-methyl selenocysteine. Selenium is used as an active center of various antioxidant enzymes in vivo, can protect DNA, protein and other cell components from oxidative damage, and is also one of important tumor prevention medicaments.

The chitosan oligosaccharide can inhibit the growth of tumor metastasis, and obviously reduce the expression of mRNA and protein thereof in the tumor, thereby inhibiting the formation of tumor blood vessels and promoting the apoptosis of tumor cells, achieving the purpose of inhibiting the growth of the tumor, and leading the tumor to be starved and dead.

Glutamine can reduce permeability of mucous membrane, maintain barrier function of intestinal mucosa, enhance intestinal immunity, reduce bacterial translocation and prevent enterogenous infection.

Soy isoflavones are a secondary metabolite formed during the growth of soybeans. The soybean isoflavone is an active ingredient extracted from soybeans, the heterocyclic polyphenol structure of the soybean isoflavone is similar to that of estrogen, therefore, the soybean isoflavone is also called phytoestrogen, and the recent research proves that the estrogen has the main effect of genistein. The research shows that: the intake of soy isoflavones is associated with the development and progression of a variety of diseases in menopausal women. Meanwhile, the intake of the soybean isoflavone is related to the occurrence and prognosis of various malignant tumors, and in vitro experiments and animal experiments prove that the soybean isoflavone has obvious tumor inhibition effect, particularly on cancers related to estrogen, such as breast cancer, endometrial cancer and ovarian cancer.

Pachymic acid is an effective active substance of traditional Chinese medicine tuckahoe, belongs to triterpenoid, and has biological effects of resisting inflammation, resisting oxidation, stopping vomiting, resisting cancer and the like. Pachymic acid promotes apoptosis by inhibiting the activation of Wnt signal path, and provides support for the prevention and treatment of renal cancer.

Then preparing the lung cancer special-purpose clinical nutritional formula food according to the following steps:

s1, weighing the vitamin C preparation, the vitamin A preparation and the vitamin E preparation according to the weight, and premixing to obtain the compound vitamin; weighing protein, polyunsaturated fat, vitamin A, vitamin C, vitamin E, vitamin D, reduced glutathione, dietary fiber, calcium, ferrum, copper, magnesium, zinc, selenium, chitosan oligosaccharide, glutamine, soybean isoflavone, curcumin and pachymic acid according to weight, sterilizing, and mixing uniformly to obtain the food raw material.

S2, packaging the food raw materials into bags with the weight of 30g per bag to form the food bags.

In summary, according to the lung cancer dedicated clinical nutritional formula food and the preparation method thereof, aiming at the poor current situations of unreasonable dietary structure, uneven nutrition and the like of lung cancer patients, protein, polyunsaturated fat, vitamin A, vitamin C, vitamin E, vitamin D, reduced glutathione, dietary fiber, calcium, iron, copper, magnesium, zinc, selenium, chitosan oligosaccharide, glutamine, soybean isoflavone, curcumin and pachymic acid are prepared in the formula, and the dietary regulation and control are mainly used for supplementing various vitamins and minerals, and matching with medicinal and edible food and new resource food to improve the nutritional structure of the lung cancer patients and assist in improving the health condition of organisms. The lung cancer special-purpose clinical nutritional formula food improves the whole body nutritional state of a patient and promotes the rehabilitation of the patient by supplementing reasonably balanced diet.

The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents and improvements made within the spirit and principle of the present invention are intended to be included within the scope of the present invention.